The relationship of immunologic testing and candidiasis to end-stage renal disease: A review article

Background: This study investigates the relationship between immunological testing, candidiasis, and end-stage kidney disease (ESKD). Individuals with a compromised immune system, such as those with ESKD, are more vulnerable to the fungal infection candidiasis. The study intends to demonstrate the influence of immunological testing on diagnosing and treating candidiasis in the setting of ESKD. Methods: Immunological assays are crucial for identifying Candida infections in individuals with ESKD and provide valuable insights into the immune response and vulnerability to fungal pathogens. This research seeks to elucidate the diagnostic and prognostic importance of immunologic markers linked to candidiasis in patients with ESKD. The research investigates the complexities of managing candidiasis in ESKD, including the impact of immunosuppression and renal insufficiency on the immune system. Results: The research thoroughly analyzes many literature sources to explore the immunological markers used for diagnosing candidiasis, emphasizing their effectiveness in distinguishing between colonization and invasive fungal infection. The research examines the challenge of treating candidiasis in individuals with ESKD, taking into account the influence of immunosuppressive medications and the need for tailored antifungal approaches. Conclusions: The findings of this study might enhance the detection, management, and treatment results of candidiasis in patients with ESKD, offering valuable insights to medical professionals, researchers, and healthcare providers caring for these individuals.